Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank60
3Y CAGR-38.0%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-38.0%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025221.42%
2024-18.17%
2023119.88%
2022928.69%
2021648.65%
20200.00%